INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Company

NRX Pharmaceuticals, Inc.

Filed

March 6, 2020

Period of Report

February 27, 2020

Accession Number

0001062993-20-001281